Results 191 to 200 of about 7,921 (224)
Intravenous lacosamide as short-term replacement for oral lacosamide in partial-onset seizures
Epilepsia, 2010 Summary Purpose: Lacosamide is a new antiepileptic drug effective for adjunctive treatment of partial-onset seizures. We evaluated the safety and tolerability of an intravenous (i.v.) formulation of lacosamide (200-800 mg/day) infused over 10, 15, and 30
Rūta Mameniškienė +2 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Expert Opinion on Investigational Drugs, 2010
Neuropathic pain remains a condition that is difficult to treat and with which therapeutic failure is not uncommon. The need for new and effective drugs to treat neuropathic pain remains strong.The available preclinical and clinical data for the pain relieving effect of lacosamide have been examined using the papers published and referenced on Medline ...
openaire +2 more sources
Neuropathic pain remains a condition that is difficult to treat and with which therapeutic failure is not uncommon. The need for new and effective drugs to treat neuropathic pain remains strong.The available preclinical and clinical data for the pain relieving effect of lacosamide have been examined using the papers published and referenced on Medline ...
openaire +2 more sources